NCT00201734 Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary Status TERMINATED Phase PHASE1/PHASE2
NCT00194792 Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer Status TERMINATED Phase PHASE2
NCT00194779 Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00194727 Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00193609 Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE2
NCT00193128 Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00193102 Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00191438 Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents Status COMPLETED Phase PHASE3
NCT00191152 A Phase III Trial For Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00182715 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00177307 Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00177255 A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers Status TERMINATED Phase PHASE2
NCT00176735 Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer Status TERMINATED Phase NA
NCT00169000 Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers Status COMPLETED Phase PHASE1
NCT00165217 Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00159432 Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00156975 Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases Status UNKNOWN Phase PHASE3
NCT00156312 Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine Status COMPLETED Phase NA